ArticleScientific data2026
HORDB 2.0: a comprehensive dataset of peptide hormones.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Peptide hormones are key signaling molecules secreted by endocrine cells that regulate vital physiological processes such as metabolism, growth, development, and reproduction. Advances in protein detection and computational approaches have led to the continuous identification of novel peptide hormones, highlighting their potential in basic research, clinical applications, and drug development. To support systematic studies in this field, we present HORDB 2.0, an open-access, manually curated dataset of peptide hormones. This dataset comprises 7,390 entries, including 7,307 peptide hormones and 83 peptide hormone drugs, corresponding to 372 marketed formulations. The dataset includes annotations on sequence, activity, structure, physicochemical properties, patents, clinical data, and literature references, where available. Additional parameters, including IC₅₀, EC₅₀, ED₅₀, and blood-brain barrier permeability, are also provided to facilitate peptide modification and drug design. HORDB 2.0 represents an expanded and enriched resource for peptide hormone research and therapeutic development, and may support downstream applications in endocrinology, pharmacology, and peptide-based drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.